Published in BMC Pulm Med on August 17, 2004
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis (2008) 2.08
Trauma: the role of the innate immune system. World J Emerg Surg (2006) 1.37
Biomarkers in acute lung injury. Transl Res (2012) 1.11
Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open (2012) 1.05
Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One (2012) 1.04
Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Inflammation (2013) 0.97
Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS One (2013) 0.92
The Esophageal Pressure-Guided Ventilation 2 (EPVent2) trial protocol: a multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure. BMJ Open (2014) 0.92
Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Respir Res (2015) 0.89
Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res (2005) 0.85
Enhanced resolution of experimental ARDS through IL-4-mediated lung macrophage reprogramming. Am J Physiol Lung Cell Mol Physiol (2016) 0.79
A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome. Dis Markers (2016) 0.75
Review: Immunology of sinusitis, trauma, asthma, and sepsis. Allergy Rhinol (Providence) (2015) 0.75
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med (1994) 27.68
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem (1993) 27.24
Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med (1983) 3.79
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 2.81
Clinical predictors of the adult respiratory distress syndrome. Am J Surg (1982) 2.62
Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.60
Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest (1995) 2.38
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11
Infections and the inflammatory response in acute respiratory distress syndrome. Chest (1997) 1.87
Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med (2000) 1.79
The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med (1996) 1.56
Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome. Crit Care Med (1998) 1.50
Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol (1993) 1.38
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J (1996) 1.35
Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax (1997) 1.27
The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS. Thorax (2002) 1.22
Microlavage: a technique for determining the volume of epithelial lining fluid. Thorax (1991) 1.18
Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut (1998) 1.16
Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J Immunol Methods (1989) 1.15
Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med (1999) 1.13
Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest (1999) 1.12
Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med (1997) 1.11
The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res (2002) 1.08
NIH conference. Airway inflammation. Ann Intern Med (1995) 1.08
Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res (1998) 0.96
Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. Eur J Clin Invest (2002) 0.86
Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med (1990) 0.85
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease. Clin Chem Lab Med (2005) 1.93
Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol (2008) 1.52
Duodenogastric reflux after biliary surgery: scintigraphic quantification and improvement with erythromycin. ANZ J Surg (2003) 1.51
Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters. Respiration (2002) 1.46
Cardiac autonomic disturbances in patients with vasovagal syndrome: comparison between iodine-123-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability. Europace (2012) 1.42
Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One (2012) 1.36
Varicella-zoster virus pneumonia in adults: report of 14 cases and review of the literature. Eur J Intern Med (2004) 1.20
Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol (2009) 1.13
Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10
The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res (2002) 1.08
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.06
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging (2006) 1.05
A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. J Infect (2009) 1.05
Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers. Prim Care Respir J (2008) 1.05
The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J (2012) 1.03
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit Care (2008) 1.02
Smoking acutely increases plasma ghrelin concentrations. Clin Chem (2006) 1.01
Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling. Br J Haematol (2010) 1.01
Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci (2007) 1.00
CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? Sleep Breath (2013) 0.98
Pleural involvement in systemic autoimmune disorders. Respiration (2008) 0.97
Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study. Ann Surg (2013) 0.96
Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? Respir Res (2006) 0.96
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Tc2 response at the onset of COPD exacerbations. Chest (2008) 0.95
Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med (2004) 0.95
Intrapleural streptokinase for pleural infection. BMJ (2006) 0.94
Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol (2012) 0.93
Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem (2007) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.92
Smoking and pulmonary fibrosis: novel insights. Pulm Med (2011) 0.92
Traumatic asphyxia due to blunt chest trauma: a case report and literature review. J Med Case Rep (2012) 0.91
Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant (2011) 0.90
Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.90
Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther (2006) 0.90
Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production. J Autoimmun (2005) 0.89
Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece. BMC Infect Dis (2009) 0.89
Parathyromatosis and the challenge of treatment. Am J Kidney Dis (2006) 0.89
Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respir Med (2008) 0.88
Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med (2008) 0.88
Respiratory, metabolic and hemodynamic effects of clonidine in ventilated patients presenting with withdrawal syndrome. Intensive Care Med (2008) 0.88
Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol (2009) 0.88
Intrapleural fibrinolytic therapy for pleural infection. Pulm Pharmacol Ther (2006) 0.87
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes (2012) 0.87
Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematol Oncol (2011) 0.87
Phase 1 trial of lipoplatin and gemcitabine as a second-line chemotherapy in patients with nonsmall cell lung carcinoma. Cancer (2008) 0.87
Association of heart rate variability and inflammatory response in patients with cardiovascular diseases: current strengths and limitations. Front Physiol (2013) 0.87
Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med (2007) 0.86
Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series. J Med Case Rep (2011) 0.86
Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome. BMC Infect Dis (2014) 0.86
Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS One (2011) 0.85
Serum biomarkers in interstitial lung diseases. Respir Res (2005) 0.85
Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res (2005) 0.85
Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis. Respir Res (2009) 0.85
Retractile mesenteritis presenting with malabsorption syndrome. Successful treatment with oral pentoxifylline. J Gastrointestin Liver Dis (2008) 0.84
Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumour Biol (2013) 0.84
Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest (2002) 0.84
Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med (2005) 0.84
Investigation of angiogenetic axis Angiopoietin-1 and -2/Tie-2 in fibrotic lung diseases: a bronchoalveolar lavage study. Int J Mol Med (2010) 0.84
Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol (2002) 0.84
Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study. Fibrogenesis Tissue Repair (2010) 0.83
Relation of heart rate variability to serum levels of C-reactive protein, interleukin 6, and 10 in patients with sepsis and septic shock. J Crit Care (2009) 0.83
Abnormal heart rate recovery immediately after treadmill testing: correlation with clinical, exercise testing, and myocardial perfusion parameters. J Nucl Cardiol (2003) 0.83
Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Invest (2013) 0.81
The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications. Exp Ther Med (2010) 0.81
Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature. Ann Clin Microbiol Antimicrob (2008) 0.81
Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol (2003) 0.81
Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: a case report. J Sex Med (2009) 0.80
Changes of heart and respiratory rate dynamics during weaning from mechanical ventilation: a study of physiologic complexity in surgical critically ill patients. J Crit Care (2010) 0.80
Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer. J Recept Signal Transduct Res (2010) 0.80
Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome. Sleep Breath (2009) 0.80
Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Pathol Res Pract (2008) 0.80
Effects of ropivacaine infiltration on cortisol and prolactin responses to postoperative pain after inguinal hernioraphy in children. J Pediatr Surg (2004) 0.80
Application of microarray technology in pulmonary diseases. Respir Res (2004) 0.80
Negative-pressure acute tracheobronchial hemorrhage and pulmonary edema. J Anesth (2009) 0.80
Sarcoidosis in a 65-year-old woman presenting with a lung mass and pericardial effusion: a case report. J Med Case Rep (2012) 0.79
A multicenter evaluation of the appropriate use of single-photon emission tomography myocardial perfusion imaging in Greece. J Nucl Cardiol (2013) 0.79
Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla? Nucl Med Commun (2009) 0.79
A patient presenting with bilateral lung lesions, pleural effusion, and proteinuria. Case Rep Med (2013) 0.79
The challenge of acute exacerbation of pulmonary fibrosis. Respiration (2011) 0.79
Short telomeres and treatment of pulmonary fibrosis: implications for early intervention. Am J Respir Crit Care Med (2009) 0.79
Massive subcutaneous emphysema as presenting finding of colonic perforation and retroperitoneal necrotizing fasciitis. Am J Emerg Med (2005) 0.78
Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease. J Clin Gastroenterol (2011) 0.78
Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma. Anticancer Res (2007) 0.78
Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol (2005) 0.78
Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP). Sarcoidosis Vasc Diffuse Lung Dis (2004) 0.78
Self-eating: friend or foe? The emerging role of autophagy in idiopathic pulmonary fibrosis. Biomed Res Int (2013) 0.78
Clinical significance of interleukin-22 in multiple myeloma. Hematology (2014) 0.78
Investigation of angiogenetic pathways in nasal polyposis. Mol Med Rep (2012) 0.77
Erdheim-Chester disease: pulmonary presentation in a case with advanced systemic involvement. Respiration (2008) 0.77